Fred Hutch health economist Gary Lyman edits essential reference book for clinical oncologists

News Releases

Fred Hutch health economist Gary Lyman edits essential reference book for clinical oncologists

Contents range from cancer biology and genetics to prevention, screening and treatment

Gary Lyman, M.D., Ph.D.

Gary Lyman, M.D., Ph.D., is co-director of the Hutchinson Institute for Cancer Outcomes Research at Fred Hutch.

Photo by Bo Jungmayer / Fred Hutch News Service

Click for high-res version

SEATTLE – Oncologist and health economist Gary Lyman, M.D., M.P.H., co-director of the Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Research Center, is editor of the second edition of the Oxford American Handbook of Oncology released this week from Oxford University Press.

The textbook is considered an essential reference for medical students, residents and clinical oncologists seeking a current resource on state-of-the-art cancer care. The reference is designed to help guide clinical decision-making, from treatment choices to best-practice guidelines.

“This represents an updated an expanded edition of the handbook, which continues in the popular bulleted style that the Oxford handbooks have made popular across a range of medical disciplines,” said Lyman, a member of the Public Health Sciences Division at Fred Hutch. The book is available in both hard-copy and digital formats.

The 864-page textbook covers cancer biology, genetics, prevention and screening, treatment complications and supportive care. The handbook also provides background on molecular cancer biology, etiology and epidemiology.

More than 50 oncology professionals from Duke University and other institutions contributed to the reference guide. Lyman, a professor of medicine at the University of Washington, also served as editor of the first edition, which was published in 2009 while he was on the faculty at Duke.

At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.

CONTACT
Kristen Woodward
206.667.2210
media@fredhutch.org